Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
2 |
1
|
2013 |
2017 |
Hereditary spherocytosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
53
|
13
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2011 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2015 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2015 |
beta^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
156
|
44
|
0.020 |
None |
1.000 |
2 |
|
1997 |
2008 |
Deficiency of glucose-6-phosphate dehydrogenase
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
75
|
20
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2016 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.020 |
None |
1.000 |
2 |
|
1992 |
1997 |
Cooley's anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
144
|
19
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2009 |
Celiac Disease
|
disease |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
527
|
263
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Glucose measurement
|
phenotype |
|
Laboratory Procedure
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
elevated blood glucose level
|
phenotype |
|
Finding
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Height
|
phenotype |
|
Organism Attribute
|
249
|
517
|
0.100 |
None |
1.000 |
1 |
2
|
2010 |
2010 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Familial cervical artery dissection
|
disease |
|
Disease or Syndrome
|
9
|
2
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Fleck corneal dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
104
|
12
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
alpha^+^ Thalassemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
92
|
16
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Primary differentiated carcinoma of thyroid gland
|
disease |
|
Neoplastic Process
|
167
|
41
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Autoimmune hepatitis type 2
|
disease |
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Differentiated Thyroid Gland Carcinoma
|
disease |
|
Neoplastic Process
|
245
|
80
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
ABO incompatibility
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |